107 related articles for article (PubMed ID: 10618534)
21. Immunization of BALB/c mice with DNA encoding equine herpesvirus 1 (EHV-1) glycoprotein D affords partial protection in a model of EHV-1-induced abortion.
Walker C; Ruitenberg KM; Love DN; Millar Whalley J
Vet Microbiol; 2000 Oct; 76(3):211-20. PubMed ID: 10973696
[TBL] [Abstract][Full Text] [Related]
22. Pathogenicity and immunogenicity of equine herpesvirus type 1 mutants defective in either gI or gE gene in murine and hamster models.
Tsujimura K; Yamanaka T; Kondo T; Fukushi H; Matsumura T
J Vet Med Sci; 2006 Oct; 68(10):1029-38. PubMed ID: 17085880
[TBL] [Abstract][Full Text] [Related]
23. A protective effect of epidermal powder immunization in a mouse model of equine herpesvirus-1 infection.
Kondo T; McGregor M; Chu Q; Chen D; Horimoto T; Kawaoka Y
Virology; 2004 Jan; 318(1):414-9. PubMed ID: 14972566
[TBL] [Abstract][Full Text] [Related]
24. Protective immunity against equine herpesvirus type-1 (EHV-1) infection in mice induced by recombinant EHV-1 gD.
Zhang Y; Smith PM; Tarbet EB; Osterrieder N; Jennings SR; O'Callaghan DJ
Virus Res; 1998 Jul; 56(1):11-24. PubMed ID: 9784062
[TBL] [Abstract][Full Text] [Related]
25. Protective effects of intranasal immunization with recombinant glycoprotein d in pregnant BALB/c mice challenged with different strains of equine herpesvirus 1.
Fuentealba NA; Zanuzzi CN; Scrochi MR; Sguazza GH; Bravi ME; Cid de la Paz V; Corva SG; Portiansky EL; Gimeno EJ; Barbeito CG; Galosi CM
J Comp Pathol; 2014 Nov; 151(4):384-93. PubMed ID: 25124330
[TBL] [Abstract][Full Text] [Related]
26. Characterisation of IE and UL5 gene products of equine herpesvirus 1 using DNA inoculation of mice.
Koen MT; Walker C; Wellington JE; Love DN; Whalley JM
Arch Virol; 2000; 145(12):2677-86. PubMed ID: 11205113
[TBL] [Abstract][Full Text] [Related]
27. The production of a truncated form of baculovirus expressed EHV-1 glycoprotein C and its role in protection of C3H (H-2Kk) mice against virus challenge.
Stokes A; Alber DG; Cameron RS; Marshall RN; Allen GP; Killington RA
Virus Res; 1996 Oct; 44(2):97-109. PubMed ID: 8879139
[TBL] [Abstract][Full Text] [Related]
28. Characteristics of equine herpesvirus 1 glycoproteins expressed in insect cells.
Whalley JM; Love DN; Tewari D; Field HJ
Vet Microbiol; 1995 Sep; 46(1-3):193-201. PubMed ID: 8545956
[TBL] [Abstract][Full Text] [Related]
29. Cytokine profiles and long-term virus-specific antibodies following immunization of CBA mice with equine herpesvirus 1 and viral glycoprotein D.
Zhang Y; Smith PM; Frampton AR; Osterrieder N; Jennings SR; O'Callaghan DJ
Viral Immunol; 2003; 16(3):307-20. PubMed ID: 14583146
[TBL] [Abstract][Full Text] [Related]
30. Interactions between equine herpesvirus type 1 and equine herpesvirus type 4: T cell responses in a murine infection model.
Azmi M; Field HJ
J Gen Virol; 1993 Nov; 74 ( Pt 11)():2339-45. PubMed ID: 8245851
[TBL] [Abstract][Full Text] [Related]
31. Immunoprotective response induced by recombinant glycoprotein D in the BALB/c respiratory mouse model of Equid alphaherpesvirus 1 infection.
Fuentealba NA; Sguazza GH; Zanuzzi CN; Bravi ME; Scrochi MR; Valera AR; Corva SG; Gimeno EJ; Pecoraro MR; Galosi CM
Rev Argent Microbiol; 2019; 51(2):119-129. PubMed ID: 30385072
[TBL] [Abstract][Full Text] [Related]
32. Expression of equine herpesvirus 1 glycoprotein D by using a recombinant baculovirus.
Love DN; Bell CW; Pye D; Edwards S; Hayden M; Lawrence GL; Boyle D; Pye T; Whalley JM
J Virol; 1993 Nov; 67(11):6820-3. PubMed ID: 8411384
[TBL] [Abstract][Full Text] [Related]
33. Study of the protective immunity of co-expressed glycoprotein H and L of equine herpesvirus-1 in a murine intranasal infection model.
Kukreja A; Love DN; Whalley JM; Field HJ
Vet Microbiol; 1998 Feb; 60(1):1-11. PubMed ID: 9595623
[TBL] [Abstract][Full Text] [Related]
34. Protective effects of recombinant glycoprotein D based prime boost approach against duck enteritis virus in mice model.
Aravind S; Kamble NM; Gaikwad SS; Shukla SK; Saravanan R; Dey S; Mohan CM
Microb Pathog; 2015 Nov; 88():78-86. PubMed ID: 26188265
[TBL] [Abstract][Full Text] [Related]
35. A hamster model of equine herpesvirus type 1 (EHV-1) infection; passive protection by monoclonal antibodies to EHV-1 glycoproteins 13, 14 and 17/18.
Stokes A; Allen GP; Pullen LA; Murray PK
J Gen Virol; 1989 May; 70 ( Pt 5)():1173-83. PubMed ID: 2471805
[TBL] [Abstract][Full Text] [Related]
36. Immunization with Attenuated Equine Herpesvirus 1 Strain KyA Induces Innate Immune Responses That Protect Mice from Lethal Challenge.
Kim SK; Shakya AK; O'Callaghan DJ
J Virol; 2016 Sep; 90(18):8090-104. PubMed ID: 27356904
[TBL] [Abstract][Full Text] [Related]
37. Antibody and cellular immune responses of naïve mares to repeated vaccination with an inactivated equine herpesvirus vaccine.
Wagner B; Goodman LB; Babasyan S; Freer H; Torsteinsdóttir S; Svansson V; Björnsdóttir S; Perkins GA
Vaccine; 2015 Oct; 33(42):5588-5597. PubMed ID: 26384446
[TBL] [Abstract][Full Text] [Related]
38. A combined bovine herpesvirus 1 gB-gD DNA vaccine induces immune response in mice.
Caselli E; Boni M; Di Luca D; Salvatori D; Vita A; Cassai E
Comp Immunol Microbiol Infect Dis; 2005 Mar; 28(2):155-66. PubMed ID: 15582691
[TBL] [Abstract][Full Text] [Related]
39. A vectored equine herpesvirus type 1 (EHV-1) vaccine elicits protective immune responses against EHV-1 and H3N8 equine influenza virus.
Van de Walle GR; May MA; Peters ST; Metzger SM; Rosas CT; Osterrieder N
Vaccine; 2010 Jan; 28(4):1048-55. PubMed ID: 19897066
[TBL] [Abstract][Full Text] [Related]
40. Equine herpesvirus 1 mutants devoid of glycoprotein B or M are apathogenic for mice but induce protection against challenge infection.
Neubauer A; Beer M; Brandmüller C; Kaaden OR; Osterrieder N
Virology; 1997 Dec; 239(1):36-45. PubMed ID: 9426444
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
